drugset / Trial / NCT07570823
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of SCTB35 in Combination With Gemcitabine and Oxaliplatin vs Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Timeline
- Start
- 2026-05
- Primary completion
- 2027-11
- Completion
- 2029-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rituxumab | Unknown | — | Intravenous |
| Subject | SCTB35 | Unknown | — | Subcutaneous |
| Background | Gemcitabine | Small molecule | — | Intravenous |
| Background | Oxaliplatin | Small molecule | — | Intravenous |